S. Hyde

发表

P95 Assessment of F/HN-pseudotyped Lentivirus as a Clinically Relevant Vector For Lung Gene Therapy

J. Davies, M. Hasegawa, D. Gill, 2012, Thorax.

Keratinocyte growth factor therapy in murine oleic acid-induced acute lung injury.

M. Goddard, D. Geddes, M. Stern, 2005, American journal of physiology. Lung cellular and molecular physiology.

Sendai virus-mediated CFTR gene transfer to the airway epithelium

A. M. Wright, D. Geddes, B. Wainwright, 2007, Gene Therapy.

S127 Gene therapy for alpha-1-antitrypsin deficiency using a pseudotyped lentivirus vector

M. Hasegawa, I. Pringle, D. Gill, 2015 .

INHERITED DISEASE RESEARCH ARTICLE Repeat administration of DNA/liposomes to the nasal epithelium of patients with cystic fibrosis

M. Evans, Leaf Huang, F. Sorgi, 2000 .

Towards gene therapy for cystic fibrosis: a clinical progress report

D. Gill, E. Alton, J. Innes, 1998, Gene Therapy.

Repeat administration of DNA/liposomes to the nasal epithelium of patients with cystic fibrosis

D. Gill, L. Huang, F. Sorgi, 2000, Gene Therapy.

Non-viral vectors in cystic fibrosis gene therapy: recent developments and future prospects

I. Pringle, D. Gill, S. Hyde, 2009, Expert opinion on biological therapy.

The multidrug resistance and cystic fibrosis genes have complementary patterns of epithelial expression.

C. Higgins, A. E. Trezíse, S. Hyde, 1992, The EMBO journal.

Measure and interpretation of CF gene therapy trial results.

D. Porteous, D. Gill, J. Innes, 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

A placebo-controlled study of liposome-mediated gene transfer to the nasal epithelium of patients with cystic fibrosis

D. Gill, F. Sorgi, D. Bilton, 1997, Gene Therapy.

A second dose of a CFTR cDNA–liposome complex is as effective as the first dose in restoring cAMP-dependent chloride secretion to null CF mice trachea

D. Gill, W. Colledge, C. Goddard, 1997, Gene Therapy.